LBO-03 - A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of cilofexor in patients with non-cirrhotic primary sclerosing cholangitis (PRIMIS)
Michael Trauner, Cynthia Levy, Atsushi Tanaka, Zachary Goodman, Douglas Thorburn, Deepak Joshi, Kimmo Salminen, Kidist Yimam, Hiroyuki Isayama, Aldo J Montano-Loza, …
LBO-03 - A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of cilofexor in patients with non-cirrhotic primary sclerosing cholangitis (PRIMIS)
Creators
Michael Trauner
Cynthia Levy
Atsushi Tanaka
Zachary Goodman
Douglas Thorburn
Deepak Joshi
Kimmo Salminen
Kidist Yimam
Hiroyuki Isayama
Aldo J Montano-Loza
Mark Danta
Holger Hinrichsen
Pietro Invernizzi
Xiangyu Liu
Xiaomin Lu
Muhsen Alani
William Barchuk
Timothy R. Watkins
Mark Genovese
Christopher Bowlus
Publication Details
Journal of hepatology, Vol.78, pp.S12-S13
Publisher
Elsevier B.V
Academic Unit
Miller School of Medicine; UMMG Dept of Medicine - Hepatology